ArticleEuropean journal of medical research2023

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.

Dechao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.